Heroids Pharmaceutical Co., Ltd
Formestane Powder

Formestane Powder

Send Inquiry

By offering Formestane Powder, we have gained wide recognition across the globe as the topmost manufacturer, exporter and supplier of steroids. This steroid is ideal for suppressing estrogen production and is also used for the treatment of breast cancer in females. Provided steroid is processed using supreme quality chemicals with the aid of advanced techniques in tune with international quality standards. In addition to this, we offer this Formestane Raw Powder at economical prices to the clients.

Formestane (Lentaron) is a steroidal aromatase inhibitor of type I. It is used to treat estrogen-receptor-positive breast cancer in women of post-menopausal. It is accessible in the form of intramuscular depot injection. Formestane is mostly used to control estrogen production from the anabolic steroids, or prohormones. Also it works as a prohormone to 4-hydroxytestosterone, which is an active steroid displaying weak androgenic activity in addition to performing as a mild aromatase inhibitor. With its poor oral bio availability, the Formestane is no longer popular as other orally active aromatase inhibitors.

Formestane Powder Quick Detail :-

Product name: Formestane
Other name: Formestaqne; Lentaron; Hydroxyandrostenedione
CAS Registry Number: 566-48-3
Assay: 98%
Packing: 1kg/aluminum foil bag
Appearance: White crystalline powder
Molecular Formula: C19H26O3
Molecular Weight: 302.41

Formestane Raw Powder Application :-

Formestane Powder is an irreversible and second-generation steroidal aromatase inhibitor. It suppresses the aromatase enzyme responsible for the conversion of androgens to estrogens. Thereby preventing the estrogen production. Breast cancer may be estrogen sensitive or estrogen insensitive. A number of breast cancers are estrogen sensitive, and such breast cancer cells depend on the estrogen for viability. Therefore, estrogen removal from the body can be effective for the treatment of hormone sensitive breast cancers. The Formestane has been specifically targeted for postmenopausal women's treatment.